Pyridoxamine reduces methylglyoxal and markers of glycation and endothelial dysfunction, but does not improve insulin sensitivity or vascular function in abdominally obese individuals: A randomized double-blind placebo-controlled trial

M.D.G. van den Eynde, A.J.H.M. Houben, J.L.J.M. Scheijen, A.M.A. Linkens, P.M. Niessen, N. Simons, N.M.J. Hanssen, Y.H.A.M. Kusters, S.J.M.P. Eussen, T. Miyata, C.D.A. Stehouwer, C.G. Schalkwijk*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Fingerprint

Dive into the research topics of 'Pyridoxamine reduces methylglyoxal and markers of glycation and endothelial dysfunction, but does not improve insulin sensitivity or vascular function in abdominally obese individuals: A randomized double-blind placebo-controlled trial'. Together they form a unique fingerprint.

Keyphrases

INIS

Medicine and Dentistry

Biochemistry, Genetics and Molecular Biology

Pharmacology, Toxicology and Pharmaceutical Science

Agricultural and Biological Sciences